Science Explorer Back to mapMap
Discussion
Researcher · Eon Corporation (United States) · United States

Jeegar P. Patel

Jeegar P. Patel publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as CAR-T cell therapy research, Immune Cell Function and Interaction and Cancer Immunotherapy and Biomarkers.

OpenAlex
World rank
#3,390,020
of 7,710,434 ranked researchers
Rank in United States
#953,837
of 1,627,098
Works
56
Citations
628
Citations per work
11.2
h-index
10
i10-index 11Top 59% in Oncology
Jeegar P. Patel

What does Jeegar P. Patel research?

Jeegar P. Patel's work is mostly in Medicine (43%), Immunology and Microbiology (21%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 24 works · 43.0% of their workMedicine: 24 works · 43.0% of their workOncology: 16 works · 29.4% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 5.6% of their workHematology: 3 works · 4.8% of their workTransplantation: 2 works · 3.2% of their workLife Sciences: 18 works · 31.7% of their workImmunology and Microbiology: 12 works · 21.4% of their workImmunology: 12 works · 21.4% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 10.3% of their workMolecular Biology: 6 works · 10.3% of their workEverything else: 14 works · 25.3% of their workTHEIR WORKJeegar P. Patel56works
Life Sciences32%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2443.0%
    1. Immunology and Microbiology1221.4%
    2. Biochemistry, Genetics and Molecular Biology610.3%
  3. Everything else1425.3%
  1. 1Oncology29% of their works
  2. 2Immunology21% of their works
  3. 3Molecular Biology10% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Hematology5% of their works
  6. 6Transplantation3% of their works

Research topics

Which keywords describe Jeegar P. Patel's research?

The keywords of their largest research topics: Cancer Immunotherapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells, NK Cell Recognition, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy212 topics
  2. Lymphoma212 topics
  3. CAR T Cells171 topic
  4. Chimeric Antigen Receptor171 topic
  5. NK Cell Recognition131 topic
  6. Natural Killer Cells131 topic
  7. Immune Checkpoint Blockade111 topic
  8. PD-1 and PD-L1111 topic
  9. Cancer Metastasis61 topic
  10. Chemokine Receptors61 topic
  11. Fc Receptors61 topic
  12. Therapeutic Antibodies61 topic
  13. Classification41 topic
  14. Dendritic Cells41 topic
  15. Immunity41 topic
  16. Kidney Transplantation41 topic
  17. Molecular Profiling41 topic
  18. Renal Allograft41 topic

Where does Jeegar P. Patel work?

Jeegar P. Patel's main affiliation in the publication record is Eon Corporation (United States), United States.

How many publications and citations does Jeegar P. Patel have?

OpenAlex counts 56 works and 628 citations for Jeegar P. Patel, an h-index of 10, ranking #3,390,020 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeegar P. Patel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.